{"id":122509,"date":"2021-05-12T00:22:29","date_gmt":"2021-05-12T07:22:29","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/05\/universal-cancer-vaccine-candidate-presents-positive-long-term-benefits"},"modified":"2021-05-12T00:22:29","modified_gmt":"2021-05-12T07:22:29","slug":"universal-cancer-vaccine-candidate-presents-positive-long-term-benefits","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/05\/universal-cancer-vaccine-candidate-presents-positive-long-term-benefits","title":{"rendered":"Universal Cancer Vaccine Candidate Presents Positive Long-term Benefits"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/universal-cancer-vaccine-candidate-presents-positive-long-term-benefits2.jpg\"><\/a><\/p>\n<p>A clinical-stage leader in immune-stimulatory vaccines for cancer announced the publication of its favorable long-term Overall Survival (OS) data from a Phase I trial evaluating a universal cancer vaccine candidate, UV1, in combination with checkpoint inhibitor ipilimumab, in patients with metastatic malignant melanoma.<\/p>\n<p>UV1 is a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen telomerase.<\/p>\n<p>Published in the <em>Frontiers in Immunology<\/em> journal on May 11, 2021, Norway-based Ultimovacs ASA\u2019s UV1 vaccine candidate achieved the primary endpoints of safety and tolerability.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A clinical-stage leader in immune-stimulatory vaccines for cancer announced the publication of its favorable long-term Overall Survival (OS) data from a Phase I trial evaluating a universal cancer vaccine candidate, UV1, in combination with checkpoint inhibitor ipilimumab, in patients with metastatic malignant melanoma. UV1 is a peptide-based vaccine inducing a specific T cell response against [\u2026]<\/p>\n","protected":false},"author":513,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,269],"tags":[],"class_list":["post-122509","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/122509","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/513"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=122509"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/122509\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=122509"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=122509"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=122509"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}